Artículos por temáticas

Transdermal rotigotine in restless legs syndrome: impulse control disorders.

[No authors listed]

Prescrire Int. 2014 Oct;23(153):239.

Opsoclonus - Myoclonus syndrome induced by phenytoin intoxication.

Verma R, Kumar S, Biyani S, Singh A.

J Neurosci Rural Pract. 2014 Nov;5(Suppl 1):S109-10. doi: 10.4103/0976-3147.145254. No abstract available.

Bladder function in patients with dystonia undergoing deep brain stimulation.

Mordasini L, Kessler TM, Kiss B, Schüpbach M, Pollo C, Kaelin-Lang A.

Parkinsonism Relat Disord. 2014 Sep;20(9):1015-7. doi: 10.1016/j.parkreldis.2014.05.016.

Cardiac safety of rasagiline, a selective monoamine oxidase type B inhibitor for the treatment of Parkinson's disease: a thorough QT/QTc study.

Mendzelevski B, Sprenger CR, Spiegelstein O, Rabinovich-Guilatt L.

Int J Clin Pharmacol Ther. 2014 Mar;52(3):192-201. doi: 10.5414/CP201955.

Genetics of Parkinson's disease: the yield.

Spatola M, Wider C.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S35-8. doi: 10.1016/S1353-8020(13)70011-7. Review.

Treatment of proximal upper limb tremor with botulinum toxin therapy.

Kim SD, Yiannikas C, Mahant N, Vucic S, Fung VS.

Mov Disord. 2014 May;29(6):835-8. doi: 10.1002/mds.25739.

Shaky drawing: what is the rate of decline during prospective follow-up of essential tremor?

Louis ED, Michalec M, Gillman A.

BMJ Open. 2014 Apr 10;4(4):e004626. doi: 10.1136/bmjopen-2013-004626.

Case report: Physical therapy management of axial dystonia.

Voos MC, Oliveira Tde P, Piemonte ME, Barbosa ER.

Physiother Theory Pract. 2014 Jan;30(1):56-61. doi: 10.3109/09593985.2013.799252.

CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.

Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A.

Parkinsonism Relat Disord. 2014 Apr;20(4):382-7. doi: 10.1016/j.parkreldis.2014.01.011.

Polysomnographic and neurometabolic features may mark preclinical autosomal dominant cerebellar ataxia, deafness, and narcolepsy due to a mutation in the DNA (cytosine-5-)-methyltransferase gene, DNMT1.

Moghadam KK, Pizza F, Tonon C, Lodi R, Carelli V, Poli F, Franceschini C, Barboni P, Seri M, Ferrari S, La Morgia C, Testa C, Cornelio F, Liguori R, Winkelmann J, Lin L, Mignot E, Plazzi G.

Sleep Med. 2014 May;15(5):582-5. doi: 10.1016/j.sleep.2013.09.028.

Stereotactic planning software for human neurotransplantation: suitability in 22 surgical cases of Huntington's disease.

Lopez WO, Nikkhah G, Schültke E, Furlanetti L, Trippel M.

Restor Neurol Neurosci. 2014;32(2):259-68. doi: 10.3233/RNN-130340.

Diagnostic challenge of pheochromocytoma in a patient receiving levodopa for Parkinson's disease.

Shimodaira M, Niwa T, Nakajima K, Kobayashi M.

Endocr Pract. 2014 Jun;20(6):e112-5. doi: 10.4158/EP13511.CR.

Freezing of gait and falls in Parkinson's disease.

Okuma Y.

J Parkinsons Dis. 2014;4(2):255-60. doi: 10.3233/JPD-130282. Review.

Neuroprotective role of liver growth factor LGF" in an experimental model of cerebellar ataxia."

Calatrava-Ferreras L, Gonzalo-Gobernado R, Reimers D, Herranz AS, Jiménez-Escrig A, Díaz-Gil JJ, Casarejos MJ, Montero-Vega MT, Bazán E.

Int J Mol Sci. 2014 Oct 21;15(10):19056-73. doi: 10.3390/ijms151019056.

Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

Quik M, Zhang D, Perez XA, Bordia T.

Pharmacol Ther. 2014 Oct;144(1):50-9. doi: 10.1016/j.pharmthera.2014.05.004. Review.